Related Experiment Video
Updated: Jul 17, 2026
10:59
Glycomics-Guided Glycoproteomics Facilitates Comprehensive Profiling of the Glycoproteome in Complex Tumor Microenvironments
Published on: February 7, 2025
Oncopeptidomics--a commentary on opportunities and limitations
Harald Tammen1, Hans-Dieter Zucht, Petra Budde
1Digilab BioVisioN GmbH, Feodor-Lynen-Str. 5, 30625 Hannover, Germany. h.tammen@biovision-discovery.de
Cancer Letters
|February 6, 2007
Summary
Oncopeptidomics analyzes peptides to find cancer biomarkers. Developing these peptide tumor markers requires extensive research and multidisciplinary collaboration, similar to drug development.
Area of Science:
- Biochemistry
- Proteomics
- Biomarker Discovery
Background:
- Cancer cells display altered protein expression and proteolytic activity.
- Endogenous peptides can reflect these pathological changes.
- Oncopeptidomics offers a method for comprehensive peptide analysis.
Purpose of the Study:
- To review current concepts and new perspectives in oncopeptidomics.
- To discuss the developmental process for clinically useful peptide tumor markers.
Main Methods:
- Mass spectrometry is a key technology for peptide profiling.
- Comprehensive multiplexed analysis of endogenous peptides.
Main Results:
- Peptides can serve as indicators of pathological changes in cancer.
- Mass spectrometry demonstrates potential for peptide biomarker discovery.
Conclusions:
- Developing reliable peptide tumor biomarkers is challenging and requires significant effort.
- A multidisciplinary approach is essential for advancing oncopeptidomics towards clinical application.
Related Concept Videos
01:33Proteomics
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
02:02Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...